Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray

Immunopharmacology

Volumn 48, Issue 2, 2000, Pages 145-156

  Gomez Flores, Ricardo ^a   Weber, Richard J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

ACTH; Buprenorphine; Corticosterone; Hypothalamic pituitary adrenal axis; Immune function; Immunosuppression; NK; Norepinephrine; Opioids; Periaqueductal gray matter; Phagocytosis; Serotonin; Sympathetic nervous system; T cells

Indexed keywords

BUPRENORPHINE; CATECHOLAMINE; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; MORPHINE; NORADRENALIN; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BUPRENORPHINE; CYTOTOXICITY, IMMUNOLOGIC; IMMUNITY, CELLULAR; INJECTIONS, INTRAVENTRICULAR; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MESENCEPHALON; MICE; MORPHINE; NEUROSECRETORY SYSTEMS; NOREPINEPHRINE; PERIAQUEDUCTAL GRAY; RATS; RATS, INBRED F344;

EID: 0034691535     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00198-3     Document Type: Article

References (45)

1. Band L.C., Pert A., Williams W., de Costa B.R., Rice K.C., Weber R.J. Central μ-opioid receptors mediate suppression of natural killer activity in vivo. Progress in Neuroendocrinimmunology. 5:1992;95-101.
2. Brema F., Pastorino G., Martini M.C., Gottlieb A., Luzzani M., Libretti A., Sacca L., Cigolari S. Oral tramadol and buprenorphine in tumour pain. International Journal of Clinical Pharmacology Research. 16:1996;109-116.
3. Brinkman W., Hall D., Gomez-Flores R., Suo J., Yan Q., Weber R.J. Microinjection of buprenorphine into the PAG: a new perspective on centrally mediated opioid-induced immunomodulation. Neuroimmunomodulation. 6:1999;A207.
4. Bryant R.M., Olley J.E., Tyers M.B. Involvement of the median raphe nucleus in antinociception induced by morphine, buprenorphine and tilidine in the rat. British Journal of Pharmacology. 77:1982;615-624.
5. Bussiere J.L., Adler M.W., Rogers T.J., Eisenstein T.K. Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacology and Immunotoxicology. 14:1992;657-673.
6. Carr D.J.J., Gebhardt B.M., Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. Journal of Pharmacology and Experimental Therapeutics. 264:1993;1179-1186.
7. Cohn L.A. Glucocorticosteroids as immunosuppressive agents. Seminars in Veterinary Medical Surgery. 12:1997;150-156.
8. El Daly E.S. Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat. Life Sciences. 59:1996;1881-1890.
9. Fang F., Proudfit H.K. Spinal cholinergic and monoamine receptors mediate the antinociceptive effect of morphine microinjected in the periaqueductal gray on the rat tail, but not the feet. Brain Research. 722:1996;95-108.
10. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. Journal of Immunology. 152:1994;5845-5852.
11. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. Journal of Pharmacology and Experimental Therapeutics. 277:1996;633-645.
12. Freier D.O., Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. Journal of Pharmacology and Experimental Therapeutics. 270:1994;1127-1133.
13. Gomez F., De Kloet E.R., Armario A. Glucocorticoid negative feedback on the HPA axis in five inbred rat strains. American Journal of Physiology. 274:1998;R420-R427.
14. Gomez-Flores R., Weber R.J. Inhibition of IL-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in NK and T cell suppression. Journal of Cytokine and Interferon Research. 19:1999;625-630.
15. Gomez-Flores R., Weber R.J. Opioids, opioid receptors, and the immune system. Plotnikoff N.P., Faith R.E., Murgo A.J., Good R.A. Cytokines-Stress and Immunity. 1999;281-314 CRC Press, Boca Raton.
16. Gomez-Flores R., Tamez-Guerra R., Tucker S.D., Mehta R.T. Bidirectional effects of IFN-γ on growth of Mycobacterium avium complex in murine peritoneal macrophages. Journal of Cytokine and Interferon Research. 17:1997;331-336.
17. Gomez-Flores R., Rodriguez-Padilla C., Mehta R.T., Galan-Wong L., Mendoza-Gamboa E., Tamez-Guerra R. Nitric oxide and TNF-alpha production by murine peritoneal macrophages activated with a novel 20-kDa protein isolated from Bacillus thuringiensis var. thuringiensis parasporal bodies. Journal of Immunology. 158:1997;3796-3799.
18. Gomez-Flores R., Jin-Liang S., Weber R.J. Suppression of splenic macrophage functions after acute morphine action in the rat mesencephalon periaqueductal gray. Brain, Behavior and Immunity. 13:1999;212-224.
19. 15N]nitrate in biological fluids. Analytical Biochemistry. 126:1982;131-138.
20. Hall D.M., Jin-Liang S., Weber R.J. Opioid mediated effects on the immune system: sympathetic nervous system involvement. Journal of Neuroimmunology. 83:1998;29-35.
21. Henrion R. Effectiveness of measures taken in France to reduce the risks of heroin addiction via intravenous route. Bulletin de l'Academie Nationale de Medecine. 181:1997;1177-1185.
22. Hilburger M.E., Adler M.W., Rogers T.J., Eisenstein T.K. Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity. Journal of Neuroimmunology. 80:1997;106-114.
23. Kaldjian E.P., Chen G.H., Cease K.B. Enhancement of lymphocyte proliferation assays by use of serum-free medium. Journal of Immunological Methods. 147:1992;189-195.
24. Kamei J., Saitoh A., Suzuki T., Misawa M., Nagase H., Kasuya Y. Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors. Life Sciences. 56:1995;L285-L290.
25. Kosten T.R., Rosen M.I., Schottenfeld R., Ziedonis D. Buprenorphine for cocaine and opiate dependence. Psychopharmacology Bulletin. 28:1992;15-19.
26. Lysle D.T., Hoffman K.E., Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. Journal of Pharmacology and Experimental Therapeutics. 277:1996;1533-1540.
27. McCarthy P.S., Howlett G.J. Physical dependence induced by opiate partial agonists in the rat. Neuropeptides. 5:1984;11-14.
28. Mello N.K., Mendelson J.H., Lukas S.E., Gastfriend D.R., Teoh S.K., Holman B.L. Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies. Harvard Review of Psychiatry. 1:1993;168-183.
29. Mellon R.D., Bayer B.M. Evidence for central opioid receptors in the immunomodulatory effects of morphine: of potential mechanism(s) of action. Journal of Neuroimmunology. 83:1998;19-28.
30. Mendelson J.H., Teoh S.K., Mello N.K., Ellinghoe J. Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. Neuropsychopharmacology. 7:1992;157-162.
31. Nowak J.E., Gomez-Flores R., Calderon S.N., Rice K.C., Weber R.J. Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80. Journal of Pharmacology and Experimental Therapeutics. 286:1998;931-937.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Sydney.
33. Pert C.B., Snyder S.H. Properties of opiate-receptor binding in rat brain. Proceedings of the National Academy of Sciences of the United States of America. 70:1973;2243-2247.
34. Pick C.G., Peter Y., Schreiber S., Weizman R. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia. Brain Research. 744:1997;41-46.
35. Rance M.J. Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs. British Journal of Clinical Pharmacology. 7:1979;281S-286S.
36. Rojavin M., Szabo I., Bussiere J.L., Rogers T.J., Adler M.W., Eisenstein T.K. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sciences. 53:1993;997-1006.
37. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proceedings of the National Academy of Sciences of the United States of America. 83:1986;7114-7117.
38. Schneider G.M., Lysle D.T. Evidence for the involvement of CNS in the modulation of splenic nitric oxide production. Journal of Neuroimmunology. 69:1996;36-38.
39. Shimizu N., Hori T., Nakane H. An interleukin-1-beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor - an in vivo microdialysis study in conscious rats. Brain Behavior and Immunity. 8:1994;14-23.
40. Suo J.-L., Weber R.J. Immunomodulation mediated by microinjection of morphine into the periaqueductal gray matter of the mesencephalon. Friedman H., Madden J.J., Thomas W.K. Drugs of Abuse, Immunomodulation, and AIDS. 1998;177-182 Plenum Press, New York.
41. Upton R.A. Simple and reliable method for serial sampling of blood from rats. Journal of Pharmaceutical Sciences. 64:1975;112-114.
42. Van Loveren H., Gianotten N., Hendriksen C.F., Schuurman H.J., Van der Laan J.W. Assessment of immunotoxicity of buprenorphine. Laboratory Animals. 28:1994;353-363.
43. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science. 245:1989;188-190.
44. Wiegers H., Labeur M.S., Stec I.E.M., Klinkert W.E.F., Holsboer F., Reul J.M.H.M. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. Journal of Immunology. 155:1995;1893-1902.
45. Williams W., Rice K.C., Weber R.J. Nonpeptide opioids: in vivo effects on the immune system. NIDA Research Monograph. 105:1991;404-407.